Chief Medical Officer
Jonathan Talamo, M.D., joined Ocular Therapeutix in 2016, bringing more than 25 years of experience as an ophthalmologist, innovator, and clinical investigator. During his career, Dr. Talamo has advised numerous early to late-stage ophthalmology companies and served as an investigator for clinical trials leading to FDA approvals of PRK, LASIK and refractive cataract surgery technologies. He was also Associate Professor of Ophthalmology at Harvard Medical School and served as Director of the Massachusetts Eye and Ear Infirmary (MEEI) Waltham, a Harvard-affiliated teaching hospital. Dr. Talamo received his M.D. degree from The Johns Hopkins University School of Medicine and completed an ophthalmology residency at the Wilmer Ophthalmological Institute at Johns Hopkins. He also completed a clinical fellowship in cornea and external disease at Massachusetts Eye and Ear Infirmary.